2nd Quarter - Report
SIDLEY AUSTIN LLP for VIFOR PHARMA LTD
Firm
Client
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Regulation of complex large-molecule drugs by the Food and Drug Administration, H.R.1576 (Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA LOUISE DELOATCHE | Health Policy Director; Sen. Orrin Hatch; Chief of Staff, Legislative Director and Legislative Assistant for Rep. Mike Bilirakis |
| PETER M GOODLOE | Legislative Counsel, House Energy & Commerce; Legislative Counsel, House Office of Legislative |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.